GEN-MKT-18-7897-A
Aug 31, 2023 | Blogs, SCIEX OS software, Technology | 0 comments
Read time: 4 minutes
Introduction In today’s rapidly evolving technological landscape, businesses heavily rely on software and IT systems to drive their operations. However, the pursuit of efficiency and speed often leads to the accumulation of what is known as technical debt. Technical debt refers to the implied cost incurred when businesses choose quick but limited solutions over better approaches that may take more time to implement. This blog post will delve into the concept of technical debt, its implications for businesses and how to avoid falling victim to its detrimental effects.
Defining technical debt Technical debt can be understood as the consequence of postponing necessary improvements or fixes to software systems, processes or infrastructure. It arises when shortcuts or suboptimal solutions are employed to meet immediate needs, resulting in compromises that can cause problems to worsen over time. Just as financial debt incurs interest over time, technical debt accumulates and becomes more costly to rectify the longer it persists.
Source: asana.com
Consider SCIEX mass spectrometry software, for instance. Analyst software offered powerful analytics for its time, but SCIEX OS software surpasses its capabilities and continues to evolve to bring more powerful acquisition and processing techniques across a broader range of SCIEX products than Analyst software could ever provide. Continued reliance on Analyst software, which is no longer updated, increases technical debt as more beneficial functionality is added to SCIEX OS software.
The consequences of accruing technical debt Growing technical debt can have a variety of consequences, including:
Source: soonersaferhappier.com
Avoiding technical debt To prevent the detrimental consequences of technical debt, businesses can adopt the following strategies:
Conclusion Technical debt is a hidden challenge that businesses must address to maintain efficiency, productivity and competitiveness. By understanding the concept, recognizing the consequences of accumulating technical debt and taking proactive measures to avoid it, businesses can help ensure they are on a path of sustainable growth. Embracing up-to-date software, leveraging automation and staying informed about industry trends empowers organizations to tackle technical debt head-on and paves the way for a successful future. SCIEX OS software represents a contribution to that effort to continuously improve and close the gap on technical debt.
Learn more >
The Echo® MS+ system is a novel platform for Acoustic Ejection Mass Spectrometry (AEMS) and combines the speed of acoustic sampling with the selectivity of mass spectrometry. This platform has been designed for high throughput analysis of small and large molecules. The technology combines Acoustic Droplet Ejection (ADE), an Open Port Interface (OPI) and could be coupled with the SCIEX Triple Quad 6500+ system or the ZenoTOF 7600 system.
The Echo® MS+ system comprises of an open-port interface (OPI) and acoustic droplet ejection (ADE) module which could be coupled with a mass spectrometer. The mass spectrometer could either be a SCIEX Triple Quad 6500+ system or the ZenoTOF 7600 system. This non-liquid chromatography based; high-throughput screening platform enables rapid analysis of compounds at speeds of up to 1 sample/second.
The ability to consistently achieve reproducible results on many complex samples across multiple days is critical to a routine clinical laboratory. Laboratories relying on analytical instrumentation require stability and robustness to perform a variety of screening and confirmatory assays with confidence. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has become the preferred analytical method in the clinical laboratory to reliably perform clinical testing as it provides best-in-class performance and reliability for the most challenging assays. LC-MS/MS offers the required levels of sensitivity and specificity for the detection and quantitation of molecules from complex biological samples, helping laboratories deliver highly accurate data for a variety of clinically relevant analytes across a wide range of assays.
Posted by
You must be logged in to post a comment.
Share this post with your network